Core Viewpoint - Rosen Law Firm is reminding investors who purchased securities of Marex Group plc during the specified Class Period of the upcoming lead plaintiff deadline on December 8, 2025, and the potential for compensation without out-of-pocket costs [1][2]. Group 1: Class Action Details - The class action lawsuit has been filed against Marex Group plc, alleging that during the Class Period, the company made materially false and misleading statements and failed to disclose critical information regarding its financial practices [4]. - Specific allegations include Marex selling over-the-counter financial instruments to itself, inconsistencies in financial statements between subsidiaries, and misleading positive statements about its business operations [4]. Group 2: Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience or resources [3]. - The Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [3].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by December 8, 2025 [4]. Group 1: Allegations Against Marex - The complaint alleges that Marex and its executives made false and misleading statements and failed to disclose critical information, including the sale of over-the-counter financial instruments to itself and inconsistencies in financial statements [6]. - Specific allegations include a multi-year accounting scheme involving off-balance-sheet entities, fictitious transactions, and misleading disclosures to hide losses and inflate profits, with examples such as a $17 million fabricated receivable and nearly $1 billion in concealed derivatives exposure [7]. - Following the release of a report by NINGI Research, Marex's stock dropped 6.2%, closing at $35.31 on heavy trading volume [8]. Group 2: Legal Proceedings and Investor Actions - Investors who suffered losses exceeding $10,000 in Marex between May 16, 2024, and August 5, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal rights [1]. - The role of lead plaintiff in the class action is designated to the investor with the largest financial interest who is typical of class members, with options for other members to either move to serve as lead plaintiff or remain absent [9]. - Faruqi & Faruqi is also seeking information from whistleblowers, former employees, and shareholders regarding Marex's conduct [10].

Core Points - A class action lawsuit has been filed against Marex Group plc on behalf of investors who purchased shares between May 16, 2024, and August 5, 2025 [1][2] - The lawsuit follows a report by NINGI Research that alleged financial improprieties, including a multi-year accounting scheme and misleading disclosures [3][4] - Marex is accused of concealing nearly $1 billion in off-balance-sheet derivatives, which inflated profits and operating cash flow [4] Company Overview - Marex Group plc is headquartered in London and provides global financial services, including trading, clearing, and risk management [2] Allegations and Impact - The complaint details discrepancies in intercompany receivables and loans across over 56 entities, amounting to multi-million-dollar discrepancies [3] - Following the release of the report, Marex's stock price fell by $2.33, or 6.2%, closing at $35.31, resulting in significant investor losses [4]

Core Viewpoint - The Gross Law Firm has issued a notice to shareholders of Marex Group plc regarding a class action lawsuit due to allegations of false statements and misleading information related to the company's financial performance [1][2]. Summary by Sections Allegations - The complaint alleges that Marex Group plc improperly inflated its cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions, leading to materially false and misleading statements about the company's business and prospects [2]. Class Period and Registration - The class period for the lawsuit is from May 16, 2024, to August 5, 2025. Shareholders who purchased shares during this period are encouraged to register for the class action [2][3]. Next Steps for Shareholders - Shareholders must register by December 8, 2025, to be considered for lead plaintiff status. Registration includes enrollment in a portfolio monitoring software for updates on the case [3]. Law Firm's Mission - The Gross Law Firm aims to protect investors' rights and ensure companies adhere to responsible business practices, seeking recovery for losses incurred due to misleading statements or omissions that artificially inflated stock prices [4].

Core Points - Rosen Law Firm is reminding purchasers of Marex Group plc securities from May 16, 2024, to August 5, 2025, about the December 8, 2025, lead plaintiff deadline [1] - Investors who purchased Marex securities during the specified period may be entitled to compensation through a contingency fee arrangement [1] Class Action Details - A class action lawsuit has been filed against Marex Group plc, with allegations of materially false and misleading statements regarding the company's financial practices [4] - Specific claims include Marex selling over-the-counter financial instruments to itself, inconsistencies in financial statements, and misleading positive statements about the company's business and prospects [4] Legal Representation - Investors are encouraged to select qualified legal counsel with a proven track record in securities class actions, as many firms may not have the necessary experience [3] - Rosen Law Firm has a history of successful settlements, including the largest securities class action settlement against a Chinese company at the time, and has recovered hundreds of millions for investors [3]

Core Viewpoint - Marex Group plc is facing a class action securities lawsuit due to alleged securities fraud that occurred between May 16, 2024, and August 5, 2025, which has adversely affected investors [1][2] Group 1: Lawsuit Details - The lawsuit claims that Marex Group plc made false statements and concealed information regarding the improper inflation of cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [2] - As a result of these actions, the positive statements made by the defendants about the Company's business and prospects were materially false and misleading [2] Group 2: Next Steps for Investors - Investors who suffered losses during the specified timeframe have until December 8, 2025, to request to be appointed as lead plaintiff, although participation in any recovery does not require serving as a lead plaintiff [3] - Class members may be entitled to compensation without any out-of-pocket costs or fees [3] Group 3: Firm Background - Levi & Korsinsky, LLP has a strong track record in securing significant recoveries for shareholders and has been recognized as one of the top securities litigation firms in the United States for seven consecutive years [4]

MRX investors may also contact Joseph E. Levi, Esq. via email at [email protected] or by telephone at (212) 363-7500. CASE DETAILS: According to the filed complaint, defendants made false statements and/or concealed that: Specifically, defendants failed to inform investors that it improperly inflated its cash flow and the revenues, assets, and profits of its Market Making segment through off-book intercompany transactions, and as a result of the above, defendants' positive statements about the Company's ...

Core Viewpoint - The Gross Law Firm is notifying shareholders of Marex Group plc regarding a class action lawsuit due to allegations of false statements and misleading information related to the company's financial performance [1][3]. Group 1: Allegations and Class Action Details - The class period for the lawsuit is from May 16, 2024, to August 5, 2025 [3]. - Allegations include that Marex Group improperly inflated its cash flow, revenues, assets, and profits in its Market Making segment through off-book intercompany transactions [3]. - The defendants' positive statements about the company's business and prospects were claimed to be materially false and misleading [3]. Group 2: Shareholder Actions and Deadlines - Shareholders are encouraged to register for the class action by December 8, 2025, to potentially be appointed as lead plaintiffs [4]. - Once registered, shareholders will receive updates through a portfolio monitoring software regarding the case's status [4]. - Participation in the case incurs no cost or obligation for shareholders [4]. Group 3: Law Firm's Mission and Commitment - The Gross Law Firm aims to protect investors' rights who have suffered from deceit and illegal business practices [5]. - The firm is dedicated to ensuring companies adhere to responsible business practices and good corporate citizenship [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Marex Group plc due to allegations of securities law violations, with a deadline for investors to seek lead plaintiff status in a class action lawsuit by December 8, 2025 [3][5]. Summary by Sections Legal Investigation - Faruqi & Faruqi, LLP is a national securities law firm that has recovered hundreds of millions of dollars for investors since its inception in 1995 [4]. - The firm is encouraging investors who purchased Marex securities between May 16, 2024, and August 5, 2025, to discuss their legal rights [3][9]. Allegations Against Marex - The complaint against Marex alleges violations of federal securities laws, including making false or misleading statements and failing to disclose critical financial inconsistencies [5]. - Specific allegations include the sale of over-the-counter financial instruments to itself, inconsistencies in financial statements, and misleading positive statements about the company's operations and prospects [5]. NINGI Research Report - A report released by NINGI Research on August 5, 2025, accused Marex of a multi-year accounting scheme involving off-balance-sheet entities and fictitious transactions to hide losses and inflate profits [6]. - The report highlighted a fabricated receivable of $17 million, inflated subsidiary profits, and nearly $1 billion in concealed derivatives exposure [6]. Market Reaction - Following the release of the NINGI Research report, Marex's stock experienced a decline of 6.2%, closing at $35.31 with heavy trading volume [7].

Accessibility StatementSkip Navigation NEW YORK, Oct. 30, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Marex Group plc (NASDAQ: MRX). Shareholders who purchased shares of MRX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/marex-group-plc-loss-submission-form/?id=174491&f ...